SUBLOCADE
These highlights do not include all the information needed to use SUBLOCADE safely and effectively. See full prescribing information for SUBLOCADE. SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use, CIII Initial U.S. Approval: 2002
6189fb21-9432-45f8-8481-0bfaf3ccde95
HUMAN PRESCRIPTION DRUG LABEL
Dec 18, 2023
Indivior Inc.
DUNS: 797408549
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
buprenorphine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
buprenorphine
Product Details
FDA regulatory identification and product classification information